Revvity (RVTY)
Supplies research tools, scientific software, and clinical diagnostics from discovery through screening.
$141.60
vs last close−1.71 (−1.19%)
Something off on this page? Send us feedback.
Next report
Oct 26, 26
in 33 days
EPS estimate
$1.28
Revenue estimate
$694.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$1.42$1.01$1.18$1.18$1.70$1.06$1.41Pending
Estimate$1.37$0.96$1.14$1.14$1.57$1.02$1.21$1.28
Surprise+3.6%+5.2%+3.5%+3.5%+8.3%+3.9%+16.5%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Feb '26May '26Aug '26Oct '26
Reported$729.4M$664.8M$720.3M$698.9M$772.1M$711.1M$711.0MPending
Estimate$665.3M$710.8M$699.9M$699.4M$764.9M$704.1M$703.0M$694.4M
Surprise+9.6%−6.5%+2.9%−0.1%+0.9%+1.0%+1.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jan 2029 | $1.74 | — | — |
| Oct 2028 | $1.57 | — | — |
| Jul 2028 | $1.59 | — | — |
| Apr 2028 | $1.53 | — | — |
| Jan 2028 | $1.71 | — | — |
| Oct 2027 | $1.43 | — | — |
| Jul 2027 | $1.47 | — | — |
| Apr 2027 | $1.26 | — | — |
| Jan 2027 | $1.62 | — | — |
| Oct 2026 | $1.28 | — | — |
| Aug 2026 | $1.21 | $1.41 | +16.5% |
| May 2026 | $1.02 | $1.06 | +3.9% |
| Feb 2026 | $1.57 | $1.70 | +8.3% |
| Oct 2025 | $1.14 | $1.18 | +3.5% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jan 2029 | $1.74 | — | — | $832.9M | — | — | — |
| Oct 2028 | $1.57 | — | — | $762.5M | — | — | — |
| Jul 2028 | $1.59 | — | — | $775.5M | — | — | — |
| Apr 2028 | $1.53 | — | — | $751.9M | — | — | — |
| Jan 2028 | $1.71 | — | — | $802.5M | — | — | — |
| Oct 2027 | $1.43 | — | — | $732.3M | — | — | — |
| Jul 2027 | $1.47 | — | — | $746.5M | — | — | — |
| Apr 2027 | $1.26 | — | — | $719.4M | — | — | — |
| Jan 2027 | $1.62 | — | — | $759.0M | — | — | — |
| Oct 26, 2026 | $1.28 | — | — | $694.4M | — | — | — |
| Aug 4, 2026 | $1.21 | $1.41 | +16.5% | $703.0M | $711.0M | +1.1% | −3.3% |
| May 5, 2026 | $1.02 | $1.06 | +3.9% | $704.1M | $711.1M | +1.0% | +6.7% |
| Feb 2, 2026 | $1.57 | $1.70 | +8.3% | $764.9M | $772.1M | +0.9% | −1.6% |
| Oct 27, 2025 | $1.14 | $1.18 | +3.5% | $699.4M | $698.9M | −0.1% | −1.8% |
| Jul 28, 2025 | |||||||
| Apr 28, 2025 | |||||||
| Jan 31, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Jul 29, 2024 | |||||||
| Apr 29, 2024 | |||||||
| Feb 1, 2024 | |||||||
| Oct 30, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 14, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 1, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 1, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |